✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Natco Pharma Ltd.

NATCOPHARM

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹15,731 Cr.
P/E
10.22

Natco Pharma Ltd.

  • Natco Pharma
  • Caplin Point Lab
  • Jubilant Pharmova
  • TJI Pharma

FAQs on Natco Pharma Ltd. Shareprice

Natco Pharma has given lower returns compared to its competitors.
Natco Pharma has grown at ~-0.87% over the last 8yrs while peers have grown at a median rate of 8.07%

Natco Pharma is not expensive.
Latest PE of Natco Pharma is 10.22, while 3 year average PE is 26.48.
Also latest EV/EBITDA of Natco Pharma is 7.65 while 3yr average is 19.99.

View FAQ's On Business

Growth Table

  • Natco Pharma Ltd.
  • Caplin Point Lab
  • Jubilant Pharmova

Balance Sheet

  • Natco Pharma Ltd.
  • Caplin Point Lab
  • Jubilant Pharmova

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Natco Pharma Ltd.
  • Caplin Point Lab
  • Jubilant Pharmova

Cash Flow

  • Natco Pharma Ltd.
  • Caplin Point Lab
  • Jubilant Pharmova

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Natco Pharma Ltd.
  • Caplin Point Lab
  • Jubilant Pharmova

Quarterly Results

  • Natco Pharma Ltd.
  • Caplin Point Lab
  • Jubilant Pharmova

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Natco Pharma Ltd. Financials

Balance sheet of Natco Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Natco Pharma is increasing.
Latest net debt of Natco Pharma is -₹2,437.4 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹4,078.7 Crs.

The profit is oscillating.
The profit of Natco Pharma is ₹1,537 Crs for TTM, ₹1,885 Crs for Mar 2025 and ₹1,388 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Natco Pharma latest dividend payout ratio is 5.7% and 3yr average dividend payout ratio is 10.66%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech